These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38452587)
1. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Rashwan HH; Taher AM; Hassan HA; Awaji AA; Kiriacos CJ; Assal RA; Youness RA Pathol Res Pract; 2024 Apr; 256():155223. PubMed ID: 38452587 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664. He JH; Han ZP; Liu JM; Zhou JB; Zou MX; Lv YB; Li YG; Cao MR J Cell Biochem; 2017 Nov; 118(11):3713-3721. PubMed ID: 28374914 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of long non-coding RNA MEG3 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by upregulating TGF-β1. Dong H; Zhang Y; Xu Y; Ma R; Liu L; Luo C; Jiang W Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):645-652. PubMed ID: 31089680 [TBL] [Abstract][Full Text] [Related]
4. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11. Liu Z; Chen JY; Zhong Y; Xie L; Li JS Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. Peng W; Si S; Zhang Q; Li C; Zhao F; Wang F; Yu J; Ma R J Exp Clin Cancer Res; 2015 Aug; 34(1):79. PubMed ID: 26253106 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma. Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807 [TBL] [Abstract][Full Text] [Related]
7. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway. Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1. Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065 [TBL] [Abstract][Full Text] [Related]
9. LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma. Li J; Jiang X; Li C; Liu Y; Kang P; Zhong X; Cui Y J Cell Physiol; 2019 Dec; 234(12):22947-22959. PubMed ID: 31119760 [TBL] [Abstract][Full Text] [Related]
10. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in Gastric Cancer. Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125 [TBL] [Abstract][Full Text] [Related]
11. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers. Al-Rugeebah A; Alanazi M; Parine NR Pathol Oncol Res; 2019 Jul; 25(3):859-874. PubMed ID: 30793226 [TBL] [Abstract][Full Text] [Related]
12. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Sun M; Xia R; Jin F; Xu T; Liu Z; De W; Liu X Tumour Biol; 2014 Feb; 35(2):1065-73. PubMed ID: 24006224 [TBL] [Abstract][Full Text] [Related]
13. MiR-126 in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: A Reappraisal with an Zailaie SA; Sergi CM Ann Clin Lab Sci; 2022 Jan; 52(1):73-85. PubMed ID: 35181620 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis. Chang W; Wang Y; Li W; Geng Z Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis. Li Y; Ren M; Zhao Y; Lu X; Wang M; Hu J; Lu G; He S Oncol Rep; 2017 Jun; 37(6):3527-3535. PubMed ID: 28440439 [TBL] [Abstract][Full Text] [Related]
16. Functions and roles of long noncoding RNA in cholangiocarcinoma. Li J; Huang L; Li Z; Zhong X; Tai S; Jiang X; Cui Y J Cell Physiol; 2019 Aug; 234(10):17113-17126. PubMed ID: 30888066 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Zhao J; Liu Y; Zhang W; Zhou Z; Wu J; Cui P; Zhang Y; Huang G Cell Cycle; 2015; 14(19):3112-23. PubMed ID: 26237576 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851 [TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo. Yao Y; Sun Y; Jiang Y; Qu L; Xu Y Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]